Paronychia induced by gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor.
Nakano
Junji
J
Nakamura
Mitsutaka
M
D000368:Aged; D000369:Aged, 80 and over; D001707:Biopsy, Needle; D004791:Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D000077156:Gefitinib; D006801:Humans; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010304:Paronychia / Q000139:chemically induced* / Q000473:pathology; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index
D004791:Enzyme Inhibitors; D011799:Quinazolines; D000077156:Gefitinib